N-Boc-1,4-cyclohexanediamine
CAS : 195314-59-1
Ref. 3D-FB15308
1g | Arrêté | ||
2g | Arrêté | ||
5g | Arrêté | ||
10g | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- Tert-butyl 4-aminocyclohexylcarbamate
- (4-Amino-Cyclohexyl)-Carbamic Acid Tert-Butyl Ester
- (4-Aminocyclohexyl)carbamic acid tert-butyl ester
- 1,1-Dimethylethyl N-(4-aminocyclohexyl)carbamate
- 1-Boc-Amino-1,4-Cyclohexanediamine
- 1-N-Boc-1,4-Cyclohexanediamine
- 4-[(Tert-Butoxycarbonyl)Amino]Cyclohexanaminium
- Boc-1,4-trans-DACH*HCl
- Butyl 4-Aminocyclohexylcarbamate
- Carbamic acid, (4-aminocyclohexyl)-, 1,1-dimethylethyl ester
- Voir d'autres synonymes
- Carbamic acid, N-(4-aminocyclohexyl)-, 1,1-dimethylethyl ester
- N-Boc-1,4-Diaminecyclohexane
- N-tert-Butoxycarbonylcis-1,4-cyclohexanediamine
- Tert-Butyl (4-Aminocyclohexyl)Carbamate
- Trans-N-box-1,4-cyclohexanediamine
- tert-Butyl 4-aminocyclohexylcarbamate
- tert-butyl N-(4-aminocyclohexyl)carbamate
- trans-1,4-Diaminocyclohexane, N1-BOC protected
N-Boc-1,4-cyclohexanediamine is a linker that is metabolized by the liver enzymes and has high affinity for the human receptor. It has been found to be an antagonist of the phenyl ring in a number of metabolic pathways. N-Boc-1,4-cyclohexanediamine is synthesized through the reaction of 1,4-cyclohexanediamine with dihydrochloride. The product yield can be optimized by optimizing the synthesis method and selectivity. The pharmacophore of this compound may be used as a lead compound in drug discovery programs.